Please assess the completion status of the following clinical trial:

Trial Title: A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects between 18 to 45 years of age, inclusive~* Body mass index between 19 kg/m2 and 31 kg/m2, inclusive~* Healthy subjects with no clinically significant abnormalities identified by a detailed medical history,~Exclusion Criteria:~* Systolic blood pressure \>130 mmHg or \<90 mmHg measured after 10 minutes in the supine position at Screening or at admission to the study center~* Heart rate \>90 bpm or \<45 bpm measured after 10 minutes in the supine position~* Electrocardiogram (ECG) finding of QTc interval \>500 msec, or other clinically significant ECG abnormality at the Screening Visit

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- TR-701 FA with Tyramine (Type: EXPERIMENTAL): TR-701 FA 200 oral with Tyramine
- Placebo-controlled with Tyramine (Type: PLACEBO_COMPARATOR): Placebo-controlled with Tyramine

Based on this trial design, predict the completion outcome and termination type (if applicable).